ASHP Guidelines on the Pharmacist's Role in the Development, Implementation, and Assessment of Critical Pathways.
Because pharmacotherapy is a central component of many critical pathways, pharmacists should take leadership roles in their development, implementation, and assessment. Pharmacists can improve the development of critical pathways by ensuring the evidence-based selection of medications, establishing measures for monitoring patients for drug efficacy and adverse effects, and evaluating the proposed critical pathway for patient safety. Pharmacists can improve the implementation of critical pathways by documenting processes and outcomes, ensuring proper patient selection and medication use, monitoring patients for drug efficacy and adverse effects, and providing for continuity of care. Pharmacists can improve the assessment of critical pathways by measuring and analyzing processes and outcomes, disseminating the results of those analyses, and reviewing the critical pathways' pharmacotherapy to keep pace with changes in best practices.
D003266:Continuity of Patient Care; D019091:Critical Pathways / Q000458:organization & administration*; D017408:Guidelines as Topic; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control; D010595:Pharmacists; D024382:Professional Role; D017749:Total Quality Management; D014481:United States